Diabetes Mellitus, Type 2: all 9,590 studies

Page 24 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.

• Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DMCompletedNCT01677299Phase 1/2Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic TherapyCompletedNCT01676220Phase 3Results posted
• The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyCompletedNCT01676116Phase 3Results posted
• Multiple Dose Study Of PF-05231023 In Adult Subjects Who Have Poor Lipid Control With And Without Type 2 Diabetes MellitusCompletedNCT01673178Phase 1Results posted
• A Study of Dulaglutide in Chinese ParticipantsCompletedNCT01667900Phase 1Results posted
• Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 DiabetesCompletedNCT01664624Phase 1Results posted
• The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment IntensificationCompletedNCT01664247Phase 3Results posted
• Drug Interaction Study of Saxagliptin in Combination With Dapagliflozin in Healthy ParticipantsCompletedNCT01662999Phase 1Results posted
• The Effect of Whole Almonds on Biomarkers of Cardiovascular Disease in Chinese Patients With Type 2 DiabetesCompletedNCT01656850Not applicableResults posted
• Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes MellitusCompletedNCT01652729Phase 3Results posted
• Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 DiabetesCompletedNCT01652716Phase 3Results posted
• Using Peer Mentors to Support PACT Team Efforts to Improve Diabetes ControlCompletedNCT01651117Not applicableResults posted
• A Single-dose Phase 1 Study of DBPR108 in Healthy Male SubjectsCompletedNCT01650324Phase 1Results posted
• Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes MellitusCompletedNCT01650259Results posted
• A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin TherapyCompletedNCT01649297Phase 2Results posted
• A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT01648582Phase 3Results posted
• Fatty Acid Radiotracer Comparison Study in Heart Failure PatientsCompletedNCT01648296Early Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 DiabetesTerminatedNCT01647542Phase 3Results posted
• Safety and Efficacy of Dapagliflozin in Triple Therapy to Treat Subjects With Type 2 DiabetesCompletedNCT01646320Phase 3Results posted
• A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes MellitusCompletedNCT01644500Phase 3Results posted
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002)CompletedNCT01640873Phase 1Results posted
• Study of Vitamin D and Omega-3 Supplementation for Preventing DiabetesCompletedNCT01633177Phase 3Results posted
• Vascular Impairment in Type II Diabetes Mellitus With Co-morbid Obstructive Sleep ApneaCompletedNCT01629862Phase 2Results posted
• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes MellitusCompletedNCT01627340Phase 4Results posted
• A Study Comparing the Effect of Dulaglutide With Liraglutide in Type 2 DiabetesCompletedNCT01624259Phase 3Results posted
• A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)CompletedNCT01621178Phase 3Results posted
• Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCompletedNCT01620489Phase 3Results posted
• Safety and Efficacy of Saxagliptin in Triple Therapy to Treat Subjects With Type 2 DiabetesCompletedNCT01619059Phase 3Results posted
• Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 DiabetesCompletedNCT01618214Phase 4Results posted
• The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin TherapyCompletedNCT01618162Phase 3Results posted
• A Comparison Chocolate With and Without High Cocoa Solids in Patients With Type 2 Diabetes in a Randomised Clinical TrialCompletedNCT01617603Not applicableResults posted
• The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesCompletedNCT01617434Phase 3Results posted
• Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)CompletedNCT01614769Phase 1Results posted
• Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseTerminatedNCT01609582Phase 3Results posted
• The Efficacy and Safety Study in Patients With Type 2 Diabetes MellitusCompletedNCT01608724Phase 4Results posted
• Modulation of Human Myocardial Metabolism by GLP-1 Dose ResponseCompletedNCT01607450Phase 2/3Results posted
• Safety and Efficacy of Combination Saxagliptin & Dapagliflozin Added to Metformin to Treat Subjects With Type 2 DiabetesCompletedNCT01606007Phase 3Results posted
• Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without MetforminCompletedNCT01596504Phase 2Results posted
• Randomized Study of Yohimbine Treatment for Type 2 Diabetes Patients Carrying a Specific Genetic Risk VariantCompletedNCT01593215Phase 2Results posted
• A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)CompletedNCT01590797Phase 3Results posted
• A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)CompletedNCT01590771Phase 3Results posted
• Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes PatientsCompletedNCT01589653Phase 4Results posted
• Efficacy Study of Pioglitazone and Metformin and Association Between Pioglitazone Response and Peroxisome Proliferator-activated Receptor Gamma Gene Variants in Bangladeshi Type 2 Diabetes Mellitus SubjectsCompletedNCT01589445Phase 4Results posted
• Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)CompletedNCT01588470Phase 4Results posted
• The Effects of LY2409021 on the LiverCompletedNCT01588366Phase 1Results posted
• Evaluation of CONTOUR® USB BGMS on Glycaemic Control in Insulin-treated Diabetic PatientsCompletedNCT01588106Results posted
• The Medication Metronome Project - Study to Facilitate Follow-up Testing Resulting From Prescribed Medications to Improve Patient Safety and CareCompletedNCT01586897Not applicableResults posted
• A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01584232Phase 3Results posted
• A Study of LY2605541 in Participants With Type 2 Diabetes MellitusCompletedNCT01582451Phase 3Results posted
• A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)CompletedNCT01582308Phase 1Results posted
• Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM SubjectsTerminatedNCT01582282Phase 4Results posted
• Safety and Efficacy of Vildagliptin Plus Metformin (SPC) Treatment in Type 2 Diabetes Mellitus PatientsCompletedNCT01582243Phase 4Results posted
• Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 DiabetesCompletedNCT01581658Phase 1Results posted
• Impact of Pharmaceutical Care in Diabetics PatientsCompletedNCT01580904Not applicableResults posted
• Evaluating the Effects of a Study Medication on Exercise Function in Type 2 DiabetesCompletedNCT01580813Not applicableResults posted
• Medium-term Health Coaching and Life-long Monitoring in Diabetes MellitusCompletedNCT01580098Not applicableResults posted
• Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 DiabetesCompletedNCT01572740Phase 3Results posted
• A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose InsulinCompletedNCT01570751Phase 3Results posted
• E-health Care Process Support for Diabetes Type II PatientsCompletedNCT01566981Not applicableResults posted
• Evaluation of Food Effect on the Pharmacokinetics of Sustained Release Metformin in Healthy Indian VolunteersCompletedNCT01561976Not applicableResults posted
• A Study of LY2189265 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT01558271Phase 3Results posted
• A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)CompletedNCT01557504Phase 1Results posted
• A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin AloneCompletedNCT01555164Phase 3Results posted
• Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 DiabetesCompletedNCT01554618Phase 3Results posted
• Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)CompletedNCT01545388Phase 3Results posted
• LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENtsCompletedNCT01544309Not applicableResults posted
• Pantoprazole on Insulin Secretion in DiabetesCompletedNCT01541735Phase 2/3Results posted
• Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesCompletedNCT01541215Phase 3Results posted
• Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2)CompletedNCT01537120Phase 1Results posted
• VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes MellitusCompletedNCT01528254Phase 4Results posted
• PK Study of Dapagliflozin in Pediatric Subjects With T2DMCompletedNCT01525238Phase 1Results posted
• Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DMTerminatedNCT01525225Phase 1Results posted
• A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual SyringeCompletedNCT01524770Phase 1Results posted
• Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and MetforminCompletedNCT01519674Phase 4Results posted
• Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on MetforminCompletedNCT01517412Phase 3Results posted
• Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On MetforminCompletedNCT01517373Phase 2Results posted
• Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic PatientsCompletedNCT01515657Phase 3Results posted
• Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin MonotherapyTerminatedNCT01514149Phase 2Results posted
• A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT01513590Phase 3Results posted
• Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 DiabetesCompletedNCT01512979Phase 4Results posted
• A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal ImpairmentCompletedNCT01512849Phase 1Results posted
• Treatment of Diabetes After Gastric Bypass With SitagliptinCompletedNCT01512797Not applicableResults posted
• Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD AloneCompletedNCT01512108Phase 3Results posted
• Adding Liraglutide to High Dose Insulin: Breaking the CycleCompletedNCT01505673Phase 4Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyCompletedNCT01499095Phase 3Results posted
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedNCT01499082Phase 3Results posted
• Impact of a Diabetes Transitions Tool Kit on Post-Hospitalization Glycemic ControlCompletedNCT01495975Not applicableResults posted
• Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes MellitusCompletedNCT01494987Phase 3Results posted
• Study of Cholesterol Levels and Types in African Americans With Type 2 DiabetesCompletedNCT01494298Results posted
• Study to Evaluate the Efficacy of Acarbose,Metformin,Sitagliptin Combination Treatment in DM PatientsCompletedNCT01490918Phase 4Results posted
• Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 DiabetesTerminatedNCT01486966Phase 4Results posted
• Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)CompletedNCT01485614Phase 3Results posted
• Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 DiabetesTerminatedNCT01481116Phase 3Results posted
• A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)TerminatedNCT01477853Phase 3Results posted
• A First-in-Human Study of LY3009385 in Healthy ParticipantsCompletedNCT01477567Phase 1Results posted
• Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic PatientsCompletedNCT01476475Phase 2Results posted
• Albiglutide Glucose Clamp Study in Subjects With Type 2 DiabetesCompletedNCT01475734Phase 2Results posted
• Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 DiabetesCompletedNCT01475461Phase 2Results posted
• Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump TherapyCompletedNCT01474538Phase 3Results posted
• QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 DiabetesCompletedNCT01474018Phase 4Results posted

← Diabetes Mellitus, Type 2 overview